Avantor's third-quarter results reflect a challenging environment, with revenues down 5% year-over-year, but management is optimistic about long-term growth and strategic revitalization efforts.

• Reported revenue of $1.62 billion, reflecting a 5% decline on an organic basis, primarily due to weaker lab segment performance.
• Adjusted EBITDA margin held steady at 16.5%, with adjusted EPS of $0.22, down $0.04 year-over-year, underscoring solid cost control amidst challenging conditions.
• The Board authorized a $500 million share repurchase program, signaling confidence in the company's long-term value and commitment to shareholder returns.
• Cash generation remains strong, with free cash flow of $172 million, contributing to a conversion rate of 124%.
• Management highlights significant untapped potential and plans to execute a comprehensive business turnaround strategy, dubbed "Avantor revival."